Garfield Alastair sold RYTM
July 2, 2025 · Form 4 insider transaction
Garfield Alastair sold 6 shares of Rhythm Pharmaceuticals, Inc. at $64.60 per share, a transaction worth $387.60. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
6
Price
$64.60
Total value
$387.60
InsiderGarfield Alastair
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 2, 2025
Filing dateJuly 3, 2025
Shares owned after3,126
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on June 25, 2024 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.